Novo Nordisk AS (OCSE:NOVO B)
kr 775.8 18.5 (2.44%) Market Cap: 3.45 Til Enterprise Value: 3.43 Til PE Ratio: 36.59 PB Ratio: 28.65 GF Score: 97/100

Novo Nordisk A/S Virtual R&D Investor Presentation Transcript

Jun 19, 2020 / 01:00PM GMT
Release Date Price: kr224.65 (+2.47%)
Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board

Presentation
Jun 19, 2020 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP, CFO & Member of the Management Board
* Mads Krogsgaard Thomsen
Novo Nordisk A/S - Executive VP, Chief Scientific Officer & Member of the Management Board
* Marcus Schindler
Novo Nordisk A/S - SVP of Global Drug Discovery
* Martin Holst Lange
Novo Nordisk A/S - SVP of Global Development

=====================
- /- -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot